Nitrome Biosciences

Better Lives Through Bold Ideas

Our Method

A New Approach

Nitrome Biosciences has discovered and identified a new class of enzymes.
As a platform company developing drugs against a newly identified class of enzymes, we will have found and characterized this class of enzymes and will have paved a novel inroad into the proprietary development of disease-modifying therapies

We are initially targeting Parkinson’s disease and developing cures for multiple aging-dependent diseases, including other neurodegenerative diseases, Type II diabetes, heart disease and cancer.

About Us

Our Team

It’s about working with the right team of people to discover, innovate, and create new therapies to improve lives.
Irene Griswold-Prenner headshot

In the News

Recognized for Our Work

We innovate to improve lives and we’ve received an impressive collection of awards and recognitions. Here are a few of our latest distinctions.

Read about our Series A funding in Business Wire

Investor logos

Want to learn more?

Get in touch to request more information or collaborate.